Eli Lilly

Total: $238.9 million

Top 2 drugs
Cialis: $88.9 million
Cymbalta (pain): $63.3 million; Cymbalta (depression): $34.9 million
Watch the Cymbalta TV commercial here >>

Eli Lilly ($LLY) has been sucking what it can out of Cymbalta while it can. The drug goes off patent at the end of the year, and the expected loss of revenues has wreaked havoc on the company. After letting 40% of its U.S. sales force go, Lilly told everyone else it would freeze salaries and reduce bonuses paid in 2015 to save $400 million through 2016. Lilly actually reported a 3% rise in worldwide revenues to $11.53 billion in the first half of the year, primarily due to--you guessed it--Cymbalta and Cialis, the two drugs it was pushing hard to consumers.

Eli Lilly
Read more on

Suggested Articles

Perrigo is treading water in its specialty drugs reinvention plan. Could a merger with another struggling drugmaker—à la Pfizer and Mylan—be the cure?

AveXis' ex-CSO is "prepared to assert his rights and defend his conduct accordingly," a statement from a lawyer who recently represented Elon…

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.